Skip to main content

Advertisement

SpringerLink
Log in

Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The Japanese severity score (JSS) for acute pancreatitis was revised in 2008. As special therapies for severe acute pancreatitis (SAP), continuous regional arterial infusion of protease inhibitor and antibiotics (CRAI) and enteral nutrition (EN) are now utilized in Japan. We investigated the usefulness of the new JSS and the indications for CRAI and EN based on the new JSS.

Methods

We assessed the new JSS in 138 patients with SAP according to the previous Japanese criteria. Usefulness of the new JSS for the prediction of mortality rates was compared with conventional scoring systems by receiver-operator characteristic curve analysis. We analyzed the relationship between the new JSS and prognosis in patients with and without CRAI and EN, respectively.

Results

Forty-five patients (33%) were assessed as having mild acute pancreatitis, and 93 patients (67%) were assessed as having SAP. Their mortality rates were 7 and 40%, respectively. The area under the curve for the prediction of mortality rates with the new JSS was 0.822 and was the highest among conventional scoring systems. In patients with new JSS ≥ 6, the mortality rate was lower in patients with CRAI than in patients without CRAI (P = 0.129). In patients with new JSS ≥ 4, the mortality rate was lower in patients with EN than in patients without EN (P = 0.016).

Conclusions

The new JSS is useful and easier to use for the prediction of prognosis compared to the conventional scoring systems. EN was effective in reducing the mortality rate in patients with a new JSS ≥ 4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med. 2004;32:2524–36.

    Article  PubMed  Google Scholar 

  2. Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:10–24.

    Article  PubMed  Google Scholar 

  3. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69–81.

    PubMed  CAS  Google Scholar 

  4. Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340–6.

    Article  PubMed  CAS  Google Scholar 

  5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.

    Article  PubMed  CAS  Google Scholar 

  6. Saitoh Y, Yamamoto M. Evaluation of severity of acute pancreatitis. According to a report of the cooperative national survey in Japan. Int J Pancreatol. 1991;9:51–8.

    PubMed  CAS  Google Scholar 

  7. Ogawa M, Hirota M, Hayakawa T, Matsuno S, Watanabe S, Atomi Y, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas. 2002;25:325–30.

    Article  PubMed  Google Scholar 

  8. Takeda K, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:42–7.

    Article  PubMed  Google Scholar 

  9. Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg. 1996;171:394–8.

    Article  PubMed  CAS  Google Scholar 

  10. Takeda K, Yamauchi J, Shibuya K, Sunamura M, Mikami Y, Matsuno S. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotic in the management of acute necrotizing pancreatitis. Pancreatology. 2001;1:668–73.

    Article  PubMed  CAS  Google Scholar 

  11. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg. 2001;8:216–20.

    Article  PubMed  CAS  Google Scholar 

  12. Imaizumi H, Kida M, Nishimaki H, Okuno J, Kataoka Y, Kida Y, et al. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas. 2004;28:369–73.

    Article  PubMed  CAS  Google Scholar 

  13. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg. 1997;84:1665–9.

    Article  PubMed  CAS  Google Scholar 

  14. McClave SA, Greene LM, Snider HL, Makk LJ, Cheadle WG, Owens NA, et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr. 1997;21:14–20.

    Article  PubMed  CAS  Google Scholar 

  15. McClave SA, Chang WK, Dhaliwal R, Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J Parenter Enteral Nutr. 2006;30:143–56.

    Article  PubMed  Google Scholar 

  16. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, et al. Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. J Gastroenterol. 2007;42:681–9.

    Article  PubMed  Google Scholar 

  17. Lusted LB. Decision-making studies in patient management. N Engl J Med. 1971;284:416–24.

    PubMed  CAS  Google Scholar 

  18. Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem. 1981;27:1569–74.

    PubMed  CAS  Google Scholar 

  19. Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17(Suppl):S15–39.

    Article  PubMed  Google Scholar 

  20. Working Party of the British Society of Gastroenterology, Association of Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and Ireland, Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut. 2005;54(Suppl 3):1–9.

    Article  Google Scholar 

  21. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg. 1993;128:586–90.

    PubMed  Google Scholar 

  22. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol. 1999;25:195–210.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This investigation was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan, and from the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Surgery, Kinki University School of Medicine, Osaka-sayama, 589-8511, Japan

    Takashi Ueda, Yoshifumi Takeyama, Takeo Yasuda, Keiko Kamei, Shumpei Satoi & Harumasa Ohyanagi

  2. Department of Surgery, Kobe University Graduate School of Medical Sciences, Kobe, 650-0017, Japan

    Hidehiro Sawa, Makoto Shinzeki, Yonson Ku & Yoshikazu Kuroda

  3. Daisen, Geriatric Health Service Facility, 155-1 Doto-cho, Naka-ku, Sakai, 599-8234, Japan

    Takashi Ueda

Authors
  1. Takashi Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshifumi Takeyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takeo Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keiko Kamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shumpei Satoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hidehiro Sawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Makoto Shinzeki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yonson Ku
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoshikazu Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Harumasa Ohyanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Ueda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueda, T., Takeyama, Y., Yasuda, T. et al. Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis. J Gastroenterol 44, 453–459 (2009). https://doi.org/10.1007/s00535-009-0026-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0026-x

Keywords

Search

Navigation